✦ LIBER ✦
1201 ORAL Early Studies of the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Anti-tumour Activity of the Humanized Monoclonal Antibody (huMAb) Anti-EGFL7 (MEGF0444A) Alone and in Combination With Bevacizumab (Bev) With and Without Paclitaxel (Pac) in Patients (pts) With Advanced Cancer
✍ Scribed by L. Rosen; P. Munster; S. Bai; P. Hegde; J. Fredrickson; R. Funke; I. Chang; D. Chen; L. Naumovski; M. Gordon
- Book ID
- 117661307
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 44 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.